Advertisement

Topics

UK 'less interesting' to pharma because of Brexit - Roche CEO

02:41 EDT 14 Sep 2018 | pharmaphorum

The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO of Roche has said, citing uncertainty over drug regulations and an unwillingness to use expensive branded drugs as potential turn-offs. Speaking to Reuters,...

Original Article: UK 'less interesting' to pharma because of Brexit - Roche CEO

NEXT ARTICLE

More From BioPortfolio on "UK 'less interesting' to pharma because of Brexit - Roche CEO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...